KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Accounts Payables (2020 - 2025)

Historic Accounts Payables for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to $649.7 million.

  • Oscar Health's Accounts Payables rose 5024.93% to $649.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $649.7 million, marking a year-over-year increase of 5024.93%. This contributed to the annual value of $649.7 million for FY2025, which is 5024.93% up from last year.
  • Oscar Health's Accounts Payables amounted to $649.7 million in Q4 2025, which was up 5024.93% from $556.7 million recorded in Q3 2025.
  • Oscar Health's Accounts Payables' 5-year high stood at $649.7 million during Q4 2025, with a 5-year trough of $121.0 million in Q1 2021.
  • Over the past 5 years, Oscar Health's median Accounts Payables value was $285.6 million (recorded in 2022), while the average stood at $332.2 million.
  • Per our database at Business Quant, Oscar Health's Accounts Payables crashed by 821.71% in 2023 and then surged by 10907.42% in 2025.
  • Quarter analysis of 5 years shows Oscar Health's Accounts Payables stood at $234.8 million in 2021, then increased by 26.86% to $297.8 million in 2022, then decreased by 8.22% to $273.4 million in 2023, then soared by 58.19% to $432.4 million in 2024, then surged by 50.25% to $649.7 million in 2025.
  • Its last three reported values are $649.7 million in Q4 2025, $556.7 million for Q3 2025, and $583.9 million during Q2 2025.